Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients.

Petejova N, Martinek A, Zahalkova J, Duricova J, Brozmannova H, Urbanek K, Grundmann M, Plasek J, Kacirova I.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158(1):65-72. doi: 10.5507/bp.2012.092. Epub 2012 Nov 6.

2.

[An effect of continuous and intermittent renal replacement therapy on antibiotic treatment in critically ill patients with sepsis - a practice-based perspective of vancomycin and gentamycin therapies].

Petejová N, Martínek A, Zahálková J, Duricová J, Plášek J, Valkovský I, Grundmann M, Kacířová I.

Vnitr Lek. 2012 Jun;58(6):448-54. Review. Czech.

PMID:
22913237
3.

Vancomycin removal during low-flux and high-flux extended daily hemodialysis in critically ill septic patients.

Petejova N, Martinek A, Zahalkova J, Duricova J, Brozmanova H, Urbanek K, Grundmann M, Kacirova I.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012 Dec;156(4):342-7. doi: 10.5507/bp.2012.002. Epub 2012 Jan 30.

4.

Gentamicin pharmacokinetics during continuous venovenous hemofiltration in critically ill septic patients.

Petejova N, Zahalkova J, Duricova J, Kacirova I, Brozmanova H, Urbanek K, Grundmann M, Martinek A.

J Chemother. 2012 Apr;24(2):107-12. doi: 10.1179/1120009X12Z.0000000006.

PMID:
22546767
5.

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R; TREAT Investigators.

N Engl J Med. 2009 Nov 19;361(21):2019-32. doi: 10.1056/NEJMoa0907845. Epub 2009 Oct 30.

6.

Improvement of cardiovascular risk factors and cosmetic side effects in kidney transplant recipients after conversion to tacrolimus.

Zadrazil J, Horak P, Zahalkova J, Strebl P, Horcicka V, Krejci K, Bachleda P, Dedochova J, Valkovsky I.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Mar;153(1):67-73.

7.

Ghrelin variants influence development of body mass index and plasma levels of total cholesterol in dialyzed patients.

Hubacek JA, Bloudícková S, Bohuslavová R, Táborský P, Polakovic V, Sazamová M, Svítilová E, Vlasák J, Sojková I, Ryba M, Knetl P, Ullrych M, Drahozal R, Pavuková V, Pavlíková B, Fischlová D, Mokrejsová M, Chmelícková H, Pauchová E, Vyskocil P, Nýdlová Z, Kopenec J, Fixa P, Hajný J, Bubenícek P, Syrovátka P, Zahálková J, Surel S, Hobzek Z, Hrubý A, Suchanová J, Vanková S, Brabcová J, Viklický O; MIA Group.

Clin Chem Lab Med. 2007;45(9):1121-3.

PMID:
17635077
8.

Endogenous erythropoietin levels and anemia in long-term renal transplant recipients.

Zadrazil J, Horák P, Horcicka V, Zahálková J, Strébl P, Hrubý M.

Kidney Blood Press Res. 2007;30(2):108-16. Epub 2007 Mar 19.

PMID:
17374961
9.

[Dual-photon bone densitometry in dialyzed patients].

Jaros A, Budíková M, Bartek J, Zadrazil J, Konecný K, Krejcí K, Vrublovský P, Zahálková J, Kosatíková Z.

Vnitr Lek. 2000 Jun;46(6):323-7. Czech.

PMID:
15645836
10.

[Anemia in chronic renal insufficiency and chronic failure].

Zahálková J.

Vnitr Lek. 2003 May;49(5):379-82. Review. Czech.

PMID:
12908172
11.

Impaired triglyceride tolerance in hemodialysis patients with different apolipoprotein E (apo E) isoforms.

Zahálková J, Vaverková H, Novotný D, Kosatíková Z.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2002 Dec;146(2):73-6. No abstract available.

12.

Dialysis activity of the Hemodialysis (HD) Center at University Hospital Olomouc in the past decade.

Zahálková J.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2002 Dec;146(2):69-72.

13.

Determination of total antioxidant capacity in plasma by cyclic voltammetry. Two case reports.

Psotová J, Zahálková J, Hrbác J, Simánek V, Bartek J.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2001 Dec;145(2):81-3.

PMID:
12426779
14.

[Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) leading to the diagnosis of Wilson's disease].

Szotkowski T, Frysák Z, Papajík T, Dusková M, Zahálková J, Tozzi I, Indrák K.

Vnitr Lek. 2002 Apr;48(4):353-6. Czech.

PMID:
12061187
15.

[Optimal therapy with erythropoietin (EPO) in patients with renal anemia on hemodialysis therapy].

Merta M, Sobotová D, Zahálková J, Bitterová Z, Jirka T, Knetl P, Kopenec J, Suchanová J, Vlasák J.

Sb Lek. 2001;102(1):41-52. Czech.

PMID:
11830918
16.

[Dyslipoproteinemia and chronic kidney failure].

Zahálková J, Vaverková H, Kristof V.

Vnitr Lek. 2000 Sep;46(9):539-46. Czech.

PMID:
11344648
17.

Single photon bone densitometry in hemodialysis patients.

Jaros A, Zadrazil J, Konecný K, Kosatíková Z, Zahálková J, Vrublovský P, Krejcí K.

Acta Univ Palacki Olomuc Fac Med. 1999;142:135-8.

PMID:
10743743
18.

[Endogenous erythropoietin in patients on regular dialysis therapy].

Zadrazil J, Bachleda P, Zahálková J.

Vnitr Lek. 1997 Oct;43(10):649-54. Czech.

PMID:
9601878
19.

[Erythropoietin and erythropoiesis after kidney transplantation].

Zadrazil J, Bachleda P, Grosmanová T, Zahálková J, Fingerová H, Petrová P, Novotný D.

Vnitr Lek. 1996 Aug;42(8):540-4. Czech.

PMID:
8967023
20.

[Iron metabolism in patients in kidney failure dialysis treatment].

Zadrazil J, Bachleda P, Papajík T, Scudla V, Zahálková J, Budíková M, Novotný D.

Acta Univ Palacki Olomuc Fac Med. 1993;135:95-7. German. No abstract available.

PMID:
7976690
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk